These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
343 related articles for article (PubMed ID: 16681755)
1. Inhibition of HPV 16 E6 oncogene expression by RNA interference in vitro and in vivo. Niu XY; Peng ZL; Duan WQ; Wang H; Wang P Int J Gynecol Cancer; 2006; 16(2):743-51. PubMed ID: 16681755 [TBL] [Abstract][Full Text] [Related]
2. [Inhibitory effect of RNA interference on expression of HPV16 E6 oncogene in cervical cancer cell line CaSki]. Niu XY; Peng ZL; Wang H Ai Zheng; 2004 Nov; 23(11):1257-62. PubMed ID: 15522169 [TBL] [Abstract][Full Text] [Related]
3. [Inhibition of HPV16 E6 oncogene in cervical cancer by RNA interference]. Niu XY; Peng ZL; Duan WQ; Wang H; Chen YY; Fan YJ; Cheng YF; Qian XL Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jan; 37(1):14-8. PubMed ID: 16468632 [TBL] [Abstract][Full Text] [Related]
4. Extended effects of human papillomavirus 16 E6-specific short hairpin RNA on cervical carcinoma cells. Bai L; Wei L; Wang J; Li X; He P Int J Gynecol Cancer; 2006; 16(2):718-29. PubMed ID: 16681752 [TBL] [Abstract][Full Text] [Related]
5. Tanshinone IIA inhibits viral oncogene expression leading to apoptosis and inhibition of cervical cancer. Munagala R; Aqil F; Jeyabalan J; Gupta RC Cancer Lett; 2015 Jan; 356(2 Pt B):536-46. PubMed ID: 25304375 [TBL] [Abstract][Full Text] [Related]
6. Gene silencing with siRNA targeting E6/E7 as a therapeutic intervention in a mouse model of cervical cancer. Jonson AL; Rogers LM; Ramakrishnan S; Downs LS Gynecol Oncol; 2008 Nov; 111(2):356-64. PubMed ID: 18755502 [TBL] [Abstract][Full Text] [Related]
7. The synergistic therapeutic effect of cisplatin with Human papillomavirus E6/E7 short interfering RNA on cervical cancer cell lines in vitro and in vivo. Jung HS; Erkin OC; Kwon MJ; Kim SH; Jung JI; Oh YK; Her SW; Ju W; Choi YL; Song SY; Kim JK; Kim YD; Shim GY; Shin YK Int J Cancer; 2012 Apr; 130(8):1925-36. PubMed ID: 21630254 [TBL] [Abstract][Full Text] [Related]
8. Withaferin A induces p53-dependent apoptosis by repression of HPV oncogenes and upregulation of tumor suppressor proteins in human cervical cancer cells. Munagala R; Kausar H; Munjal C; Gupta RC Carcinogenesis; 2011 Nov; 32(11):1697-705. PubMed ID: 21859835 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of cervical cancer cell growth by human papillomavirus virus-like particles packaged with human papillomavirus oncoprotein short hairpin RNAs. Bousarghin L; Touze A; Gaud G; Iochmann S; Alvarez E; Reverdiau P; Gaitan J; Jourdan ML; Sizaret PY; Coursaget PL Mol Cancer Ther; 2009 Feb; 8(2):357-65. PubMed ID: 19174559 [TBL] [Abstract][Full Text] [Related]
10. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells. Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252 [TBL] [Abstract][Full Text] [Related]
11. Highly potent and specific siRNAs against E6 or E7 genes of HPV16- or HPV18-infected cervical cancers. Chang JT; Kuo TF; Chen YJ; Chiu CC; Lu YC; Li HF; Shen CR; Cheng AJ Cancer Gene Ther; 2010 Dec; 17(12):827-36. PubMed ID: 20885450 [TBL] [Abstract][Full Text] [Related]
12. Intratumor injection of small interfering RNA-targeting human papillomavirus 18 E6 and E7 successfully inhibits the growth of cervical cancer. Fujii T; Saito M; Iwasaki E; Ochiya T; Takei Y; Hayashi S; Ono A; Hirao N; Nakamura M; Kubushiro K; Tsukazaki K; Aoki D Int J Oncol; 2006 Sep; 29(3):541-8. PubMed ID: 16865269 [TBL] [Abstract][Full Text] [Related]
13. Systemic delivery of siRNA by actively targeted polyion complex micelles for silencing the E6 and E7 human papillomavirus oncogenes. Nishida H; Matsumoto Y; Kawana K; Christie RJ; Naito M; Kim BS; Toh K; Min HS; Yi Y; Matsumoto Y; Kim HJ; Miyata K; Taguchi A; Tomio K; Yamashita A; Inoue T; Nakamura H; Fujimoto A; Sato M; Yoshida M; Adachi K; Arimoto T; Wada-Hiraike O; Oda K; Nagamatsu T; Nishiyama N; Kataoka K; Osuga Y; Fujii T J Control Release; 2016 Jun; 231():29-37. PubMed ID: 26979870 [TBL] [Abstract][Full Text] [Related]
14. Antisense targeting human papillomavirus type 16 E6 and E7 genes contributes to apoptosis and senescence in SiHa cervical carcinoma cells. Sima N; Wang S; Wang W; Kong D; Xu Q; Tian X; Luo A; Zhou J; Xu G; Meng L; Lu Y; Ma D Gynecol Oncol; 2007 Aug; 106(2):299-304. PubMed ID: 17586029 [TBL] [Abstract][Full Text] [Related]
15. [Effect of siRNA inhibiting HPV16 E6 gene expression on proliferation and cell cycle of cervical cancer cell line CaSki]. Guan LL; Peng ZL; Niu XY; Wang HJ; Wang DQ Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Jan; 39(1):10-4. PubMed ID: 18390189 [TBL] [Abstract][Full Text] [Related]
16. RNA interference against HPV16 E7 oncogene leads to viral E6 and E7 suppression in cervical cancer cells and apoptosis via upregulation of Rb and p53. Sima N; Wang W; Kong D; Deng D; Xu Q; Zhou J; Xu G; Meng L; Lu Y; Wang S; Ma D Apoptosis; 2008 Feb; 13(2):273-81. PubMed ID: 18060502 [TBL] [Abstract][Full Text] [Related]
17. Transcriptional gene silencing of HPV16 E6/E7 induces growth inhibition via apoptosis in vitro and in vivo. Zhou J; Peng C; Li B; Wang F; Zhou C; Hong D; Ye F; Cheng X; Lü W; Xie X Gynecol Oncol; 2012 Feb; 124(2):296-302. PubMed ID: 22056554 [TBL] [Abstract][Full Text] [Related]
18. Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference. Jiang M; Milner J Oncogene; 2002 Sep; 21(39):6041-8. PubMed ID: 12203116 [TBL] [Abstract][Full Text] [Related]
19. RNA interference against human papillomavirus oncogenes in cervical cancer cells results in increased sensitivity to cisplatin. Putral LN; Bywater MJ; Gu W; Saunders NA; Gabrielli BG; Leggatt GR; McMillan NA Mol Pharmacol; 2005 Nov; 68(5):1311-9. PubMed ID: 16120770 [TBL] [Abstract][Full Text] [Related]
20. [Relationship between nitric oxide in cervical microenvironment and different HPV types and effect on cervical cancer cells]. Wei XM; Wang Q; Gao SJ; Sui L Zhonghua Fu Chan Ke Za Zhi; 2011 Apr; 46(4):260-5. PubMed ID: 21609578 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]